Managing inflammatory bowel disease: what to do when the best is unaffordable?
- PMID: 36871567
- DOI: 10.1016/S2468-1253(23)00062-6
Managing inflammatory bowel disease: what to do when the best is unaffordable?
Conflict of interest statement
We declare no competing interests.
Comment on
-
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission.Lancet Gastroenterol Hepatol. 2023 May;8(5):458-492. doi: 10.1016/S2468-1253(23)00003-1. Epub 2023 Mar 2. Lancet Gastroenterol Hepatol. 2023. PMID: 36871566 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
